News Quantified

NBRV – nabriva therapeutics plc - ordinary shares (US:NASDAQ)

Stock Stats

News Stats


All News	{{AllNewsCount}}
News Wires	{{NewsWiresCount}}
Media Monitoring	{{MoreOverCount}}
SEC Edgar Filings	{{SecEdgarFilingsCount}}
Upgrades	{{UpgradesCount}}
Downgrades	{{DowngradesCount}}
Initiated	{{InitiatesCount}}
Reiterated	{{ReiteratesCount}}
Last Earnings	{{LastEarnings}}
Last Earnings EPS	{{LastEps}}
Next Earnings	{{NextEarnings}}

Order Stats

Sub-Penny
{{SubPennyStr}}
Odd Lot
{{OddLotStr}}
Avg. bid-ask spread

{{GetAvgBidAskSpreadForScale}}
Avg. bid / ask size
{{GetAvgBidSizeForScale}} {{GetAvgAskSizeForScale}}

Shares at ask / bid
{{SharesAtAsk_AMP_Str}} {{SharesAtBid_AMP_Str}}
Off exchange
{{OffExchange}}

News

Nabriva Therapeutics plc (NASDAQ: NBRV) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.

Top News Decliners

3/12 Q4/2019 12/31/2019 EPS -0.290 ZacksConsensus -0.330 ActVsEst 0.040 - Beat -43.6%

12/20 Form 8-K Nabriva Therapeutics For: Dec 20 -32.6%

8/19 Form 8-K Nabriva Therapeutics For: Aug 16 -20.6%

3/18 Nabriva Therapeutics PLC - (NASDAQ: NBRV) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -18.0%

6/21 Nabriva Therapeutics to Present Data at ASM Microbe Demonstrating Potential of Lefamulin for Patients with Community-acquired Bacterial Pneumonia (CABP) and CONTEPO™ (fosfomycin) for injection to Treat Complicated Urinary Tract Infections (cUTIs) -10.5%

6/24 Nabriva Therapeutics Announces European Medicines Agency (EMA) Validation of Marketing Authorization Application for Lefamulin -8.3%

3/10 Nabriva Therapeutics to Report 2019 Financial Results and Recent Corporate Highlights on March 12, 2020 -7.6%

1/4 Nabriva Therapeutics PLC - (NASDAQ: NBRV) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -6.9%

8/5 Form 8-K Nabriva Therapeutics For: Jul 31 -6.2%

11/14 Nabriva Therapeutics PLC - (NASDAQ: NBRV) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -5.2%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}